Find Telitacicept manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

API REF. PRICE (USD/KG)

$
$ 0

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Regulatory FDF Prices

NA

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

0

API

0

FDF

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Telitaciceptum, Tai'ai, Telitacicept [inn], Telitacicept [who-dd], 1fhm3d7z49, 2136630-26-5
Molecular Formula
C44H26I4N4
Molecular Weight
1118.3  g/mol
InChI Key
BIHWRSWVZVTYDW-UHFFFAOYSA-N

Telitacicept
Telitacicept is a fusion protein composed of the extracellular domain of human tumor necrosis factor receptor superfamily member 13B (TNFRSF13B; transmembrane activator and calcium modulator and cyclophilin ligand interactor; TACI) fused to a human immunoglobulin (Ig) fragment crystallizable (Fc) domain, with potential immunomodulating activity. Upon administration, telitacicept targets both tumor necrosis factor ligand superfamily member 13B (TNFSF13B; BAFF; B lymphocyte stimulator; BLyS) and tumor necrosis factor ligand superfamily member 13 (TNFSF13; a proliferation-inducing ligand; APRIL) and inhibits their interaction with their cell membrane receptors, including TACI, tumor necrosis factor receptor superfamily member 17 (TNFRSF17; B-cell maturation antigen; BCMA) and tumor necrosis factor receptor superfamily member 13C (TNFRSF13C; BAFF receptor; BAFF-R). This inhibits B-cell proliferation and maturation, thereby inhibiting B-cell mediated autoimmune responses. APRIL and BAFF, and their interactions with their receptors TACI, BCMA and BAFF-R, play important roles in in B-cell proliferation and survival.
1 2D Structure

Telitacicept

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
5,10,15,20-tetrakis(3-iodophenyl)-21,23-dihydroporphyrin
2.1.2 InChI
InChI=1S/C44H26I4N4/c45-29-9-1-5-25(21-29)41-33-13-15-35(49-33)42(26-6-2-10-30(46)22-26)37-17-19-39(51-37)44(28-8-4-12-32(48)24-28)40-20-18-38(52-40)43(36-16-14-34(41)50-36)27-7-3-11-31(47)23-27/h1-24,49,52H
2.1.3 InChI Key
BIHWRSWVZVTYDW-UHFFFAOYSA-N
2.2 Synonyms
2.2.1 Depositor-Supplied Synonyms

1. Telitaciceptum

2. Tai'ai

3. Telitacicept [inn]

4. Telitacicept [who-dd]

5. 1fhm3d7z49

6. 2136630-26-5

7. (l120>a,l121>e,g123>a,a216>s,p217>s)-taci (transmembrane Activator And Caml Interactor, Tumor Necrosis Factor Receptor Superfamily Protein Tnfrsf13b) Human Extracellular Domain Fragment (13-118)-peptide (1-106) Fusion Protein With Human Immunoglobulin G1

8. 13-118-tumor Necrosis Factor Receptor Superfamily Protein Tnfrsf13b (human Extracellular Domain Fragment) Fusion Protein With Immunoglobulin G1, (human Rc18 Fc Fragment), Dimer

9. (l120>a,l121>e,g123>a,a216>s,p217>s)-taci (transmembrane Activator And Caml Interactor, Tumor Necrosis Factor Receptor Superfamily Protein Tnfrsf13b) Human Extracellular Domain Fragment (13-118)-peptide (1-106) Fusion Protein With Human Immunoglobulin G1-(227 C-terminal Residues)-peptide (.gamma.1-chain Fc Fragment) (107-333) (homo Sapiens Ighg1*01, Hinge (107-116), Ch2 L120>a, L121>e, G123>a, A216>s, P217>s (117-226), Ch3 (227-331), Chs (332-333)), (112-112':115-115')-bisdisulfide Dimer,

10. (l120>a,l121>e,g123>a,a216>s,p217>s)-taci (transmembrane Activator And Caml Interactor, Tumor Necrosis Factor Receptor Superfamily Protein Tnfrsf13b) Human Extracellular Domain Fragment (13-118)-peptide (1-106) Fusion Protein With Human Immunoglobulin G1-(227 C-terminal Residues)-peptide (gamma1-chain Fc Fragment) (107-333) (homo Sapiens Ighg1*01, Hinge (107-116), Ch2 L120>a, L121>e, G123>a, A216>s, P217>s (117-226), Ch3 (227-331), Chs (332-333)), (112-112':115-115')-bisdisulfide Dimer,

11. 5,10,15,20-tetrakis(3-iodophenyl)porphyrin

12. 107643-76-5

13. Tetra-(3-iodophenyl)porphin

2.3 Create Date
2019-01-25
3 Chemical and Physical Properties
Molecular Weight 1118.3 g/mol
Molecular Formula C44H26I4N4
XLogP313
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count2
Rotatable Bond Count4
Exact Mass Da
Monoisotopic Mass Da
Topological Polar Surface Area57.4
Heavy Atom Count52
Formal Charge0
Complexity1010
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

Treatment of Systemic Lupus Erythematosus (SLE)


ABOUT THIS PAGE

Looking for 2136630-26-5 / Telitacicept API manufacturers, exporters & distributors?

Telitacicept manufacturers, exporters & distributors 1

52

PharmaCompass offers a list of Telitacicept API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Telitacicept manufacturer or Telitacicept supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Telitacicept manufacturer or Telitacicept supplier.

PharmaCompass also assists you with knowing the Telitacicept API Price utilized in the formulation of products. Telitacicept API Price is not always fixed or binding as the Telitacicept Price is obtained through a variety of data sources. The Telitacicept Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Telitacicept

Synonyms

Telitaciceptum, Tai'ai, Telitacicept [inn], Telitacicept [who-dd], 1fhm3d7z49, 2136630-26-5

Cas Number

2136630-26-5

About Telitacicept

Telitacicept is a fusion protein composed of the extracellular domain of human tumor necrosis factor receptor superfamily member 13B (TNFRSF13B; transmembrane activator and calcium modulator and cyclophilin ligand interactor; TACI) fused to a human immunoglobulin (Ig) fragment crystallizable (Fc) domain, with potential immunomodulating activity. Upon administration, telitacicept targets both tumor necrosis factor ligand superfamily member 13B (TNFSF13B; BAFF; B lymphocyte stimulator; BLyS) and tumor necrosis factor ligand superfamily member 13 (TNFSF13; a proliferation-inducing ligand; APRIL) and inhibits their interaction with their cell membrane receptors, including TACI, tumor necrosis factor receptor superfamily member 17 (TNFRSF17; B-cell maturation antigen; BCMA) and tumor necrosis factor receptor superfamily member 13C (TNFRSF13C; BAFF receptor; BAFF-R). This inhibits B-cell proliferation and maturation, thereby inhibiting B-cell mediated autoimmune responses. APRIL and BAFF, and their interactions with their receptors TACI, BCMA and BAFF-R, play important roles in in B-cell proliferation and survival.

Telitacicept Manufacturers

A Telitacicept manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Telitacicept, including repackagers and relabelers. The FDA regulates Telitacicept manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Telitacicept API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

Telitacicept Suppliers

A Telitacicept supplier is an individual or a company that provides Telitacicept active pharmaceutical ingredient (API) or Telitacicept finished formulations upon request. The Telitacicept suppliers may include Telitacicept API manufacturers, exporters, distributors and traders.

Telitacicept GMP

Telitacicept Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Telitacicept GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Telitacicept GMP manufacturer or Telitacicept GMP API supplier for your needs.

Telitacicept CoA

A Telitacicept CoA (Certificate of Analysis) is a formal document that attests to Telitacicept's compliance with Telitacicept specifications and serves as a tool for batch-level quality control.

Telitacicept CoA mostly includes findings from lab analyses of a specific batch. For each Telitacicept CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Telitacicept may be tested according to a variety of international standards, such as European Pharmacopoeia (Telitacicept EP), Telitacicept JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Telitacicept USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty